Identity
- Security key
- 12730
- Ticker
- BNTC
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2012-07-11
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- BNTC
Detail
Enriched 2026-08-14 20:47
- Market cap
- $423,932,481.56
- Shares outstanding (class)
- 34,354,334
- Shares outstanding (weighted)
- 34,354,334
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 19
- Location
- HAYWARD, CA
- Homepage
- https://www.benitec.com
- Description
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.